Dextera Surgical

Redwood City, United States Founded: 1997 • Age: 29 yrs Acquired By Aesculap
Stapling devices for minimally invasive laparoscopic surgeries
Request Access
Report Incorrect Data
Annual revenue $3.4M Latest available
Total funding - 3 rounds
Employees 15 Tracked headcount
Investors 1 Known backers
Products 3 Services tracked
Competitors 9 Brand Intelligence

About Dextera Surgical

Dextera Surgical is a company based in Redwood City (United States) founded in 1997 was acquired by Aesculap in February 2018. The company has 15 employees as of June 30, 2017. Dextera Surgical offers products and services including MicroCutter 5/80, Cardiac Specialties, and Thoracic Specialties. Dextera Surgical operates in a competitive market with competitors including Endoron Medical, Bolder Surgical, revmedica, Reach Surgical and C2Dx, among others.

  • Headquarter Redwood City, United States
  • Employees 15 as on 30 Jun, 2017
  • Stage Public
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
Operational Areas
Healthcare → Medical Devices & Diagnostics → Unlock Sub-Sector → Unlock Segment
Key Metrics
  • Annual Revenue
    $3.42 M (USD)
    -16
    as on Jun 30, 2017
  • Net Profit
    -$17.23 M (USD)
    -8
    as on Jun 30, 2017
  • EBITDA
    -$14.6 M (USD)
    6
    as on Jun 30, 2017
  • Latest Funding Round
    $600 K (USD), Post-IPO

    Dec 22, 2010

  • Investors
    Aesculap
  • Employee Count
    15

    as on Jun 30, 2017

  • Acquired by
    Aesculap

    (Feb 21, 2018)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Dextera Surgical

Dextera Surgical offers a comprehensive portfolio of products and services, including MicroCutter 5/80, Cardiac Specialties, and Thoracic Specialties.

Product name locked
Category locked
Primary

Enables minimally invasive procedures for faster lung cancer recovery.

Product name locked
Category locked
Locked

Supports cardiac surgeries with advanced minimally invasive techniques.

Product name locked
Category locked
Locked

Facilitates thoracic operations for improved patient outcomes.

Funding Insights of Dextera Surgical

Investors in Dextera Surgical

Dextera Surgical has secured backing from 1 investor. Prominent investors backing the company include Aesculap.

All
Investor Description Founded Year Domain Location
Aesculap
Surgical equipment is manufactured and pay-per-use services are offered.
Locked Locked Locked
Premium access

Investor details for Dextera Surgical

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Dextera Surgical

Investments
Premium access

Investment portfolio details for Dextera Surgical

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Dextera Surgical

Premium access

Detailed financials for Dextera Surgical

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Dextera Surgical Comparisons

Dextera Surgical Primary company
Description
Stapling devices for minimally invasive laparoscopic surgeri...
Location
Redwood City, United States
Founded Year
1997
Annual Revenue
$3.42 M (USD)
Net Profit
-$17.23 M (USD)
EBITDA
-$14.6 M (USD)
Employees
15
As of 2017
Premium access

Peer comparison for Dextera Surgical

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Dextera Surgical

Dextera Surgical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Endoron Medical, Bolder Surgical, revmedica, Reach Surgical and C2Dx, among others.

Company Name Domain Founded year HQ Location Description
Endoron Medical
Locked Locked Locked
Endovascular fixation devices for cardiovascular stent grafts are manufactured.
Bolder Surgical
Locked Locked Locked
Developer of electrosurgical device for pediatric patients
revmedica
Locked Locked Locked
Laparoscopic surgical staplers are developed for minimally invasive procedures.
Reach Surgical
Locked Locked Locked
Surgical staplers and energy devices are manufactured and distributed globally.
C2Dx
Locked Locked Locked
Provider of medical products and related services
Amplify Surgical
Locked Locked Locked
Provider of various surgical solutions
Premium access

Detailed competitors of Dextera Surgical

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Dextera Surgical

Dextera Surgical Obtains Approval for Asset Sale to Aesculap, Inc.
Businesswire • 8 years ago
Dextera Surgical's (DXTR) CEO Julian Nikolchev on Q4 2017 Results
Seekingalpha • 8 years ago
Premium access

Complete news archive for Dextera Surgical

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Dextera Surgical

Dextera Surgical was founded in 1997 and raised its 1st funding round 12 years after it was founded.

Dextera Surgical is headquartered in Redwood City, United States. It is registered at Redwood City, California, United States.

As of Jun 30, 2017, the latest employee count at Dextera Surgical is 15.

Annual revenue of Dextera Surgical is $3.42M as on Jun 30, 2017.

Dextera Surgical, formerly known as Cardica, develops stapling devices that are used in minimally invasive laparoscopic, video-assisted or robotic-assisted surgical procedures. Product offering includes MicroCutter 580, a five-millimeter surgical stapler that articulates to 80 degrees in each direction; C-Port distal anastomosis systems and PAS-Port proximal anastomosis system for coronary artery bypass graft surgery.

Dextera Surgical's top competitors include Bolder Surgical, revmedica and Amplify Surgical.

Dextera Surgical offers MicroCutter 5/80, Cardiac Specialties, and Thoracic Specialties.

Dextera Surgical has 1 investor. Key investors include Aesculap.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available